Sign up today: https://investorshub.advfn.com/?imd=278713
Followers | 971 |
Posts | 382,998 |
Boards Moderated | 6 |
Alias Born | 06/24/2011 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thin back to .08's!
#5 on the breakout boards, golden opportunity, adding!
$NBIO NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announced today it has entered into a research collaboration agreement with Manhattan BioSolutions, Inc. (Manhattan Bio), an emerging biotech company focused on precision biologics, to explore antibody-drug conjugates (ADCs) using Nascent's lead clinical candidate pritumumab (PTB) as the tumor-targeting antibody element.
Pritumumab (PTB) is a natural human antibody. This monoclonal antibody targets extracellular form of vimentin, a protein that has been linked to cancer growth and metastasis and is overexpressed in both brain and pancreatic cancers as well as other hard tumor cancers. PTB is a targeted immunotherapy that binds to vimentin in tumors and recruits the immune system to eliminate cancer cells. PTB has demonstrated a promising safety profile and preliminary efficacy in completed Phase I study in glioblastoma patients. Nascent has been recently cleared by the FDA to begin Phase II clinical trials for brain cancer.
A steal here now on the pullback.
Way oversold, loading up at these levels.
$NBIO February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announced today it has entered into a research collaboration agreement with Manhattan BioSolutions, Inc. (Manhattan Bio), an emerging biotech company focused on precision biologics, to explore antibody-drug conjugates (ADCs) using Nascent's lead clinical candidate pritumumab (PTB) as the tumor-targeting antibody element.
$NBIO Collaboration to Explore Pritumumab Antibody-Drug Conjugates https://finance.yahoo.com/news/nascent-biotech-manhattan-biosolutions-collaborate-120000090.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
$NBIO new alert: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates https://finance.yahoo.com/news/nascent-biotech-manhattan-biosolutions-collaborate-120000090.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
$NBIO The Company Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates https://finance.yahoo.com/news/nascent-biotech-manhattan-biosolutions-collaborate-120000090.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
NBIO Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates https://finance.yahoo.com/news/nascent-biotech-manhattan-biosolutions-collaborate-120000090.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
On watch for news!
Customer service technology is the new heartbeat of 1606 Corp. We understand that in the rapidly evolving world of CBD e-commerce, staying ahead requires more than just adaptation; it demands innovation. With newly developed team of diverse experts ranging from software engineers and data scientists to AI specialists and UX designers, we are determined to push the boundaries of what's possible in CBD education and online product recommendation. https://cbdw.ai/
A compound annual growth rate (CAGR) ranging from 33.2% to 38.1%, AI’s global impact is undeniable, with as many as 97 million individuals expected to work in the AI sector by 2025, according to fortunebusinessinsights.com
The A.I. market has seen remarkable growth, valued at $428 billion in 2022 and projected to reach $2.25 trillion by 2030.
"As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction."
"We are dedicated to transforming the CBD industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience."
For more information on ChatCBDW, investor updates, and our future endeavors, please visit our website www.CBDW.ai.
Our commitment to transforming the CBD industry through cutting-edge AI-centric solutions is stronger than ever and that’s why we’ve partnered with Cool Blue Distribution, one of the country’s largest suppliers of CBD and Cannasite, a top rated website development company also focused on CBD merchants.
"We anticipate a profitable second quarter, and we’re poised for rapid expansion thanks to our ISO expansion model, and thanks to our visionary approach and strategic initiatives we’re signing new ISO’s monthly."
Looking Ahead: A Vision for 2024 and Beyond
As we progress into 2024, our focus remains steadfast on innovation, quality, and customer satisfaction as we plan to release V2 of ChatCBDW in early Summer 2024.
The global artificial intelligence market’s remarkable growth, valued at $428 billion in 2022 and projected to reach $2.25 trillion by 2030, places us at the forefront of this rapidly evolving sector.
The partnership with Cool Blue Distribution and the integration of a second large Independent Sales Organization (ISO), CannaSite is a testament to our commitment to expanding our reach and enhancing our technological capabilities.
Participation in the Consumer Electronics Show (CES) in Las Vegas and the formation of a dedicated sales team for ChatCBDW have further cemented our position as a leader in AI-driven conversational merchandising. We are not just revolutionizing the CBD industry; we are redefining customer engagement across all online platforms.
These achievements in signing merchants and onboarding new customers underscores the high demand and scalability of our AI solutions in the competitive digital landscape.
The overwhelming response to the ChatCBDW BETA program, and our exceptional December 2023 marketing program results signifying a pivotal moment in our history.
"As we embark on another pioneering year at CBDW.ai, we are thrilled to share the remarkable milestones and exponential growth achieved in the past year. Our journey, underscored by the successful implementation and market reception of ChatCBDW, our AI-driven merchandising chatbot, heralds a new era of innovation and customer engagement in the CBD industry."
An industry leader in the development of AI-powered merchandising chatbots, is pleased to announce its Chairman and CEO, Greg Lambrecht has issued a letter to shareholders. https://cbdw.ai/1606-corp-launches-an-era-of-exceptional-growth-of-cbdw-ai-for-e-commerce/
$CBDW CEO Greg Lambrecht anticipates a profitable second quarter, and says they’re poised for rapid expansion thanks to their ISO expansion model. https://cbdw.ai/1606-corp-launches-an-era-of-exceptional-growth-of-cbdw-ai-for-e-commerce
$CBDW is Leading the AI Merchandising Bot Revolution, Validated by Google’s Latest Move https://cbdw.ai/how-1606-corp-is-leading-the-ai-merchandising-bot-revolution-validated-by-googles-latest-move
1606 Corp prepares for major launch of proprietary platform ChatCBDW chatbot https://finance.yahoo.com/news/1606-corp-prepares-major-launch-172300982.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Embracing a monthly licensing model for ChatBots as a Software as a Service (SaaS) solution brings a host of advantages to businesses seeking to harness the potential of AI-driven conversational tools. With this model, companies can enjoy the flexibility of predictable monthly payments, which simplifies budgeting and cost management. This approach eliminates the need for a substantial upfront investment, making ChatBots accessible to startups and small businesses with limited resources.
Moreover, a monthly licensing model ensures that businesses are always up to date with the latest features and improvements in their ChatBot. These regular updates and enhancements are typically included in the subscription fee, enabling companies to stay ahead of the curve in terms of customer engagement and automation capabilities.
Additionally, the scalability of a monthly licensing model allows businesses to adapt to changing needs effortlessly. They can adjust the number of licenses or features to accommodate fluctuations in customer demand or organizational growth, providing the agility required in today's fast-paced business environment.
In summary, the combination of a monthly licensing model with ChatBot SaaS not only eases financial management but also guarantees ongoing innovation and scalability, enabling companies to offer top-notch customer service while optimizing their resources efficiently.
1606 Corp starts campaign to bring ChatCBDW to over 3,000 CBD merchants throughout the US https://finance.yahoo.com/news/1606-corp-starts-campaign-bring-182451405.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Merchandiser Customization and Collaboration At 1606 Corp
We understand that no two businesses are the same. Therefore, our approach to provide customer service solutions for online CBD retailers centers around collaboration and customization. We aim to work closely with our clients to comprehend their unique online sales challenges, goals, and aspirations. Through our team effort with our partners to develop tailor-made smart solutions that not only address immediate customer needs but will also lay the groundwork for sustained enterprise success.
The participation in CES aligns with 1606 Corp.'s mission to stay at the forefront of technological innovation for AI chatbot deployment. "CES is the perfect platform for us to explore cutting-edge technologies and form strategic alliances. Our focus is not just on advancing our chatbot technology but also on how AI can overall enhance customer experience and operational efficiencies for small businesses nationwide," said Greg Lambrecht.
1606 Corp. Accounts Skyrocket After December AI ChatBot Launch Leading to Expected Profitability in 2024 https://finance.yahoo.com/news/1606-corp-accounts-skyrocket-december-133000797.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
$CBDW
Loading zone.
The Rising Trend of Retail Chatbot Usage: The retail industry is increasingly embracing chatbot technology to meet the evolving needs of the digital consumer. Chatbots offer a range of benefits including 24/7 customer service, personalized shopping experiences, and efficient handling of customer inquiries. This trend is reflective of a broader shift towards AI-driven solutions in the retail sector, which is why we believe CBDW is in the right place at the right time.
Greg Lambrecht, CEO of 1606 Corp., expressed his enthusiasm: "The immediate onboarding of customers through our partnership with CannaSite is a testament to the market's readiness for advanced AI solutions. We are not only witnessing swift integration of our chatbots but also the tremendous potential for revenue and growth with web platform sales in partnership with CannaSite."
SEATTLE, Jan. 25, 2024 /PRNewswire/ -- 1606 Corp. (Stock Symbol: CBDW), an industry leader in the development of AI-powered merchandising chatbots, is pleased to announce a remarkable achievement related to its brand new partnership with Cannasite, a reseller of CBDW's AI-driven merchandising chatbot. Within just three days of signing the partnership with CannaSite, CBDW has successfully closed multiple new chatbot customers. This instant impact of revenue growth underscores the effectiveness and readiness of our marketing strategies.
Time to accumulate.